Ask
Search
My library
ORKG

ORKG Ask

Our mission is to organize scholarly knowledge and make it accessible to humans and machines.

About

About ORKG Ask
Report issue
Statistics
Contact

Legal

Terms of use
Data protection (sheet)
Imprint
Accessibility
License

Technical

We
open source
System status
Changelog
Frontend: v1.41.0
Backend: v1.13.4

We use cookies to provide a better user experience.

Data Protection

Abciximab‐Associated Thrombocytopenia After Previous Tirofiban‐Related Thrombocytopenia

Dorsch, Michael P.
Montague, Debbie
Rodgers, Jo Ellen
Patterson, Cam

Publication date

March 2006

DOI

10.1592/phco.26.3.423

Publisher

Wiley

ISSN

0277-0008

Journal

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy

Citation count (estimate)

5

Abstract

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90080/1/phco.26.3.423.pd

Extracted data

Related items

Eptifibatide-induced acute profound thrombocytopenia in a patient with left main artery plaque rupture complicated by cardiogenic shock and gastrointestinal bleeding

Savvy Nandal
William Van Gaal
Francis A Ponnuthurai

January 2021

Eptifibatide inhibits platelet aggregation by reversibly binding to the platelet receptor glycoprote...

Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy

Sane, David C
Damaraju, Lakshmi V
Topol, Eric J
Cabot, Catherine F
Mascelli, Mary Ann
Harrington, Robert A
Simoons, Maarten L
Califf, Robert M

July 2000

AbstractOBJECTIVESThis study determined the incidence of pseudothrombocytopenia during abciximab the...

Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization

Berkowitz, Scott D.
Sane, David C.
Sigmon, Kristina N.
Shavender, Jane H.
Harrington, Robert A.
Tcheng, James E.
Topol, Eric J.
Califf, Robert M.

August 1998

AbstractObjectives. This study sought to determine the frequency of thrombocytopenia and its relatio...

Abciximab-Associated Thrombocytopenia After Previous

Tirofiban-related Thrombocytopenia
Cam Patterson M. D

September 2016

A 62-year-old man with a history of coronary artery disease and coronary artery bypass graft, chroni...

Tirofiban-induced acute profound thrombocytopenia after primary angioplasty

Dursunoğlu, Dursun
Taşköylü, Ö.
Gür, S.
Sari, I.

January 2013

Glycoprotein IIb/IIIa inhibitors are used in the acute coronary syndromes and percutaneous coronary ...

Tirofiban-induced acute profound thrombocytopenia after primary angioplasty.

Dursunoglu D
Taskoylu O
Gür S
Sari I

January 2013

Glycoprotein IIb/IIIa inhibitors are used in the acute coronary syndromes and percutaneous coronary ...

Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting

Merlini PA
Rossi M
Menozzi A
Buratti S
Brennan DM
Moliterno DJ
Topol EJ
Ardissino D

January 2004

Background-Thrombocytopenia is a possible complication of treatment with glycoprotein (GP) IIb/IIIa ...

Severe Acute Thrombocytopenia After Treatment with Tirofiban: A Case Series Approach

Gian-Manuel Jiménez-Rodríguez
Patricia Carmona-Levario
José-Alberto Ayón-Martínez
Aleksandra Gasecka
Luis Eduardo Juárez-Orozco
Antonio Reyes-Ortega
Patricia Espinosa-González
Gyna Alejandra Altamirano-Solorzano
Guering Eid-Lidt

April 2023

Glycoprotein IIb/IIIa inhibitors are an adjuvant therapy for the treatment of patients with acute co...

Acute serious thrombocytopenia associated with intracoronary tirofiban use for primary angioplasty

Yurtdaş, M.
Yaylalı, Yalın Tolga
Aladaǧ, N.
Özdemir, M.
Atay, M.H.

January 2014

Tirofiban, a specific glycoprotein IIb/IIIa inhibitor, may cause extensive thrombocytopenia with an ...

Abciximab induced severe thrombocytopenia in an elderly patient

Sen, Aastha
Bhatti, Neena
Joseph, Girish
Gautam, Vinay

December 2022

Abciximab is a humanized monoclonal antibody which acts against αIIbβ3 receptor. The use of abcixima...

Profound thrombocytopenia after abciximab administration in acute myocardial infarction and stent thrombosis following thrombocytopenia remission - a case report

Elikowski, Waldemar
Rzeźniczak, Janusz
Słomczyński, Marek
Psuja, Piotr

December 2005

Profound thrombocytopenia after abciximab administration in acute myocardial infarction and stent th...

Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s)

Sem A. O. F. Rikken
Arnoud W. J. van 't Hof
Jurriën M. ten Berg
Dean J. Kereiakes
Barry S. Coller

December 2023

Thrombocytopenia is a rare but serious complication of the intravenous glycoprotein IIb/IIIa (GPIIb/...

James C Coons
Robert A Barcelona
Tucker Freedy
Michael F Hagerty

September 2016

Glycoprotein (GP) IIb/IIIa inhibitors are potent an-tiplatelet agents integral to the management of ...

Case Report Acute Serious Thrombocytopenia Associated with Intracoronary Tirofiban Use for Primary Angioplasty

Mustafa Yurtdag
Yalin Tolga Yaylali
Nesim Aladal
Mahmut Özdemir
Memighilmi Atay

August 2016

Copyright © 2014 Mustafa Yurtdas ̧ et al.This is an open access article distributed under theCreativ...

Tirofiban Induced Thrombocytopenia: A Rare but Severe Adverse Effect

Muhammad Shabbir Rawala
Amna Saleem Ahmed
Kanna Posina
Varun Sundaram

March 2020

With the advent of medical technology, coronary angiography is a common practice to evaluate patient...

Eptifibatide-induced acute profound thrombocytopenia in a patient with left main artery plaque rupture complicated by cardiogenic shock and gastrointestinal bleeding

Savvy Nandal
William Van Gaal
Francis A Ponnuthurai

January 2021

Eptifibatide inhibits platelet aggregation by reversibly binding to the platelet receptor glycoprote...

Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy

Sane, David C
Damaraju, Lakshmi V
Topol, Eric J
Cabot, Catherine F
Mascelli, Mary Ann
Harrington, Robert A
Simoons, Maarten L
Califf, Robert M

July 2000

AbstractOBJECTIVESThis study determined the incidence of pseudothrombocytopenia during abciximab the...

Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization

Berkowitz, Scott D.
Sane, David C.
Sigmon, Kristina N.
Shavender, Jane H.
Harrington, Robert A.
Tcheng, James E.
Topol, Eric J.
Califf, Robert M.

August 1998

AbstractObjectives. This study sought to determine the frequency of thrombocytopenia and its relatio...

Abciximab-Associated Thrombocytopenia After Previous

Tirofiban-related Thrombocytopenia
Cam Patterson M. D

September 2016

A 62-year-old man with a history of coronary artery disease and coronary artery bypass graft, chroni...

Tirofiban-induced acute profound thrombocytopenia after primary angioplasty

Dursunoğlu, Dursun
Taşköylü, Ö.
Gür, S.
Sari, I.

January 2013

Glycoprotein IIb/IIIa inhibitors are used in the acute coronary syndromes and percutaneous coronary ...

Tirofiban-induced acute profound thrombocytopenia after primary angioplasty.

Dursunoglu D
Taskoylu O
Gür S
Sari I

January 2013

Glycoprotein IIb/IIIa inhibitors are used in the acute coronary syndromes and percutaneous coronary ...

Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting

Merlini PA
Rossi M
Menozzi A
Buratti S
Brennan DM
Moliterno DJ
Topol EJ
Ardissino D

January 2004

Background-Thrombocytopenia is a possible complication of treatment with glycoprotein (GP) IIb/IIIa ...

Severe Acute Thrombocytopenia After Treatment with Tirofiban: A Case Series Approach

Gian-Manuel Jiménez-Rodríguez
Patricia Carmona-Levario
José-Alberto Ayón-Martínez
Aleksandra Gasecka
Luis Eduardo Juárez-Orozco
Antonio Reyes-Ortega
Patricia Espinosa-González
Gyna Alejandra Altamirano-Solorzano
Guering Eid-Lidt

April 2023

Glycoprotein IIb/IIIa inhibitors are an adjuvant therapy for the treatment of patients with acute co...

Acute serious thrombocytopenia associated with intracoronary tirofiban use for primary angioplasty

Yurtdaş, M.
Yaylalı, Yalın Tolga
Aladaǧ, N.
Özdemir, M.
Atay, M.H.

January 2014

Tirofiban, a specific glycoprotein IIb/IIIa inhibitor, may cause extensive thrombocytopenia with an ...

Abciximab induced severe thrombocytopenia in an elderly patient

Sen, Aastha
Bhatti, Neena
Joseph, Girish
Gautam, Vinay

December 2022

Abciximab is a humanized monoclonal antibody which acts against αIIbβ3 receptor. The use of abcixima...

Profound thrombocytopenia after abciximab administration in acute myocardial infarction and stent thrombosis following thrombocytopenia remission - a case report

Elikowski, Waldemar
Rzeźniczak, Janusz
Słomczyński, Marek
Psuja, Piotr

December 2005

Profound thrombocytopenia after abciximab administration in acute myocardial infarction and stent th...

Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s)

Sem A. O. F. Rikken
Arnoud W. J. van 't Hof
Jurriën M. ten Berg
Dean J. Kereiakes
Barry S. Coller

December 2023

Thrombocytopenia is a rare but serious complication of the intravenous glycoprotein IIb/IIIa (GPIIb/...

James C Coons
Robert A Barcelona
Tucker Freedy
Michael F Hagerty

September 2016

Glycoprotein (GP) IIb/IIIa inhibitors are potent an-tiplatelet agents integral to the management of ...

Case Report Acute Serious Thrombocytopenia Associated with Intracoronary Tirofiban Use for Primary Angioplasty

Mustafa Yurtdag
Yalin Tolga Yaylali
Nesim Aladal
Mahmut Özdemir
Memighilmi Atay

August 2016

Copyright © 2014 Mustafa Yurtdas ̧ et al.This is an open access article distributed under theCreativ...

Tirofiban Induced Thrombocytopenia: A Rare but Severe Adverse Effect

Muhammad Shabbir Rawala
Amna Saleem Ahmed
Kanna Posina
Varun Sundaram

March 2020

With the advent of medical technology, coronary angiography is a common practice to evaluate patient...

Eptifibatide-induced acute profound thrombocytopenia in a patient with left main artery plaque rupture complicated by cardiogenic shock and gastrointestinal bleeding

Savvy Nandal
William Van Gaal
Francis A Ponnuthurai

January 2021

Eptifibatide inhibits platelet aggregation by reversibly binding to the platelet receptor glycoprote...

Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy

Sane, David C
Damaraju, Lakshmi V
Topol, Eric J
Cabot, Catherine F
Mascelli, Mary Ann
Harrington, Robert A
Simoons, Maarten L
Califf, Robert M

July 2000

AbstractOBJECTIVESThis study determined the incidence of pseudothrombocytopenia during abciximab the...

Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization

Berkowitz, Scott D.
Sane, David C.
Sigmon, Kristina N.
Shavender, Jane H.
Harrington, Robert A.
Tcheng, James E.
Topol, Eric J.
Califf, Robert M.

August 1998

AbstractObjectives. This study sought to determine the frequency of thrombocytopenia and its relatio...